5-HT and NA reuptake inhibitors and appetite regulation: The role of the central 5-HT network

Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry

Volumn 8, Issue 4, 2008, Pages 303-310

  Nonogaki, Katsunori ^a  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; FATTY ACID; FENFLURAMINE; FLUOXETINE; FLUVOXAMINE; LEPTIN; MELANOCORTIN 4 RECEPTOR; MILNACIPRAN; PROOPIOMELANOCORTIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SIBUTRAMINE;

APPETITE; ARTICLE; BINGE EATING DISORDER; BULIMIA; CLINICAL TRIAL; CONSTIPATION; DOWN REGULATION; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG POTENCY; ENERGY BALANCE; FEEDING BEHAVIOR; GENE FUNCTION; GENE MUTATION; HORMONE ACTION; HUMAN; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSOMNIA; LIFESTYLE MODIFICATION; NAUSEA; NONHUMAN; OBESITY; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; SATIETY; SEROTONIN RELEASE; SEROTONIN UPTAKE; SIGNAL TRANSDUCTION; THERMOGENESIS; XEROSTOMIA;

EID: 70350089200     PISSN: 18715222     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152208787169198     Document Type: Article

References (101)

1. Friedman, J.M.; Halaas J.L. Nature, 1998, 395, 763.
2. Friedman, J.M. Nat. Med., 2004, 10, 563.
3. Gura, T. Science, 1999, 29, 881.
4. Nonogaki, K.; Strack, A.; Dallman, M.; Tecott, L.H. Nat. Med., 1998, 4, 1152.
5. Nonogaki, K.; Nozue, K.; Oka, Y. Endocrinology, 2007, 147, 5893.
6. Simansky, K.J. Behav. Brain Res., 1995, 73, 37.
7. Tecott, L.H.; Sun, L.M.; Akana, S.F.; Strack, A.M.; Lowenstein, D.H.; Dallman, M.F.; Julius, D. Nature, 1995, 374, 542.
8. Vickers, S.P.; Clifton, P.G.; Dourish, C.T.; Tecott, L.H. Psychopharmacology, 1999, 143, 309.
9. Vickers, S.P.; Dourish, C.T.; Kennett, G.A. Neuropharmacology, 2001, 41, 200.
10. Connolly, H.M.; Crary, J.L.; McGoon, M.D.; Hensrud, D.D.; Edeards, B.S.; Edwards W.D.; Schaff, H.V. N. Engl. J. Med., 1997, 337, 581.
11. Gura, T. Science, 2003, 299, 849.
12. Wooltorton, E. C.M.A.J., 2002, 166, 1307.
13. Nisoli, E.; Carruba, M.O. Drug Safety, 2003, 26, 1027.
14. Hutson, P.H.; Donohoe, T.P.; Curzon, G. Psychopharmacology, 1988, 95, 550.
15. Leibowitz, S.F.; Weiss, G.F.; Suh, J.S. Pharmacol. Biochem. Behav., 1990, 37, 735.
16. Pasqualetti, M.; Ori, M.; Castagna, M.; Marazziti, D.; Cassano, G.B.; Nardi, I. Neuroscience, 1999, 92, 601.
17. Schwartz, D.; Hernandez, L.; Hoebel, B.G. Brain Res., 1989, 482, 261.
18. Paez, X.; Leibowitz, S.F. Pharmacol. Biochem. Behav., 1993, 46, 933.
19. Shor-Posner, G.; Grinker, J.A.; Marinescu, C.; Brown, O.; Leibowitz, S.F. Brain Res. Bull., 1986, 17, 663.
20. Cowley, M.A.; Smart, J.L.; Rubinstein, M.; Cerdan, M.G.; Diano, S.; Horvath, T.L.; Cone, R.D.; Low, M.J. Nature, 2001, 411, 480.
21. Saper, C.B.; Loewy, A.D. Brain Res., 1980, 197, 291.
22. Hoyer, D.; Clarke, D.E.; Fozard, J.R.; Hartig, P.R.; Martin, G.R.; Mylecharane, E.J.; Saxena, P.R.; Humphrey, P.P. Pharmacol. Rev., 1994, 46, 157.
23. Conn, P.J.; Sanders-Bush, E.; Hoffman, B.J.; Hartig, P. Proc. Natl. Acad. Sci. USA, 1986, 83, 4086.
24. Julius, D.; MacDermott, A.B.; Axel, R.; Jessell, T.M. Science, 1988, 241, 558.
25. Yagaloff, K.A.; Hartig, P.R. J. Neurosci., 1985, 5, 3178.
26. Baxter, G.; Kennett, G.; Blaney, F.; Blackburn, T. Trends. Pharmacol. Sci., 1995, 16, 105.
27. Wright, D.E.; Seroogy, K.B.; Lundgren, K.H.; Davis, B.M.; Jennes, L. J. Comp. Neurol., 1995, 351, 357.
28. Hoffman, B.J.; Mezey, E. FEBS Lett., 1989, 247, 453.
29. Pasqualetti, M.; Ori, M.; Castagna, M.; Marazziti, D.; Cassano, G.B.; Nardi, I. Neuroscience, 1999, 92, 601.
30. Petrov, T.; Krukoff, T.L.; Jhamandas, J.H. J. Comp. Neurol., 1992, 318, 18.
31. Steinbusch, H.W.; Nieuwenhuys, R. Adv. Exp. Med. Biol., 1981, 133, 7.
32. Bruinvels, A.T.; Landwehrmeyer, B.; Gustafson, E.L.; Durkin, M.M.; Mengod, G.; Branchek, T.A.; Hoyer, D.; Palacios, J.M. Neuropharmacology, 1994, 33, 367.
33. Hedlund, P.B.; Sutcliffe, J.G. Trends. Pharmacol. Sci., 2004, 25, 481.
34. Tecott, L.H. Cell Metab., 2007, 6, 352.
35. Nonogaki, K.; Strack, A.; Dallman, M.; Tecott, L.H. Nat. Med., 1998, 4, 1152.
36. Nonogaki, K.; Nat. Med., 1999, 5, 742.
37. Nonogaki, K,; Ohba, Y.; Sumii, M.; Oka, Y. Biochem. Biophys. Res. Commun., 2008, 372, 186.
38. Heisler, L.K.; Cowley, M.A.; Tecott, L.H.; Fan, W.; Low, M.J.; Smart, J.L.; Rubinstein, M.; Tatro, J.B.; Marcus, J.N.; Holstege, H.; Lee, C.E.; Cone, R.D.; Elmquist, J.K. Science, 2002, 297, 609.
39. Barnes, N.M.; Sharp, T. Neuropharmacology, 1999, 38, 1083.
40. Lee, M.D.; Somerville, E.M.; Kennett, G.A.; Dourish, C.T.; Clifton, P.G. Eur. J. Neurosci., 2004, 19, 3017.
41. Lee, M.D.; Somerville, E.M.; Kennett, G.A.; Dourish, C.T.; Clifton, P.G. Psychopharmacology, 2004, 176, 39.
42. Bouwknecht, J.A.; van, der, Gugten, J.; Hijzen, T.H.; Maes, R.A.; Hen, R.; Olivier, B. Physiol. Behav., 2001, 74, 507.
43. Lucas, J.J.; Yamamoto, A.; Scearce-Levie, K.; Saudou, F.; Hen, R. J. Neurosci., 1998, 18, 5537.
44. Halford, J.C.; Blundell, J.E. Physiol. Behav., 1996, 60, 933.
45. Lee, M.D.; Simansky, K.J. Psychopharmacology, 1997, 131, 264.
46. Dalton, G.L.; Lee, MD.; Kennett, G.A.; Dourish, C.T.; Clifton, P.G. Psychopharmacology, 2006, 185, 45.
47. Nonogaki, K.; Nozue, K.; Takahashi, Y.; Yamashita, N.; Hiraoka, S.; Kumano, H.; Kuboki, T.; Oka, Y. Int. J. Neuropsychopharmacol., 2007, 10, 675.
48. Heisler, L.K.; Jobst, E.E.; Sutton, G.M.; Zhou, L.; Borok, E.; Thornton-Jones, Z.; Liu, H.Y.; Zigman, J.M.; Balthasar, N.; Kishi, T.; Lee, C.E.; Aschkenasi, C.J.; Zhang, C.Y.; Yu, J.; Boss, O.; Mountjoy, K.G.; Clifton, P.G.; Lowell, B.B.; Friedman, J.M.; Horvath, T.; Butler, A.A.; Elmquist, J.K.; Cowley, M.A. Neuron, 2006, 51, 239.
49. Broberger, C. Brain Res., 1999, 848, 101.
50. Elias, C.F.; Lee, C.E.; Kelly, J.F.; Ahima, R.S.; Kuhar, M.; Saper, C.B.; Elmquist, J.K. J. Com. Neurology., 2001, 432, 1.
51. Oh-I. S.; Shimizu, H.; Satoh, T.; Okada, S.; Adachi, S.; Inoue, K.; Eguchi, H.; Yamamoto, M.; Imaki, T.; Hashimoto, K.; Tsuchiya, T.; Monden, T.; Horiguchi, K.; Yamada, M.; Mori, M. Nature, 2006, 443, 709.
52. Nonogaki, K.; Ohashi-Nozue, K.; Oka, Y. Biochem. Biophys. Res. Commun., 2006, 341, 703.
53. Lu, D.; Willard, D.; Patel, IR.; Kadwell, S.; Overton, L.; Kost, T.; Luther, M.; Chen, W.; Wiychik, R.P.; Wilkison, W.O.; Cone, R.D. Nature, 1994, 371, 799.
54. Nonogaki, K.; Nozue, K.; Oka, Y. Endocrinology, 2006, 147, 5893-5900.
55. Huszar, D.; Lynch, C.A.; Fairchild-Huntress, V.; Dunmore, J.H.; Fang, Q.; Berkemeier, L.R.; Gu, W.; Kesterson, R.A.; Boston, B.A.; Cone, R.D.; Smith, F.J.; Campfield, L.A.; Burn, P.; Lee, F. Cell, 1997, 88, 131.
56. Nonogaki, K, Diabetologia, 2000, 43, 533.
57. Marsh, D.J.; Hollopeter, G.; Huszar, D.;Laufer, R.; Yagaloff, K.A.; Fisher, S.L.; Burn, P.; Palmiter, R.D. Nat. Genet., 1999, 21, 119.
58. Heiler, L.K.; Pronchuk, N.; Nonogaki, K.; Zhou, L.; Raber, J.; Tung, L.; Yeo, G.S.H.; O'Rahilly, S.; Colmers, W.F.; Elmquist, J.K.; Tecott, L.H. J. Neurosci., 2007, 27, 6956.
59. Nonogaki, K.; Nozue, K.; Kuboki, T.; Oka, Y. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2007, 292, 1175.
60. Sawchenko, P.E.; Swanson, L.W.; Steinbusch, H.W.; Verhofstad, A.A. Brain Res., 1983, 277, 355.
61. Nieuwenhuizen, A.G.; Rutters, F.; Physiol. Behav., 2008, 94, 169.
62. Bovetoo, S.; Rouillard, C.; Richard, D. Am. J. Physiol., 1996, 271, R1231.
63. Cremers, T.I.; Giorgetti, M.; Bosker, F.J.; Hogg, S.; Arnt, J.; Mork, A.; Honig, G.; Bogeso, KP.; Westerink, B.H.; den, Boer, H.; Wikstrom, H.V.; Tecott, L.H. Neuropsychopharmacology, 2004, 29, 1782.
64. Wong, D.T.; Reid, L.R.; Threlkeld, P.G. Pharmaol. Biochem. Behav., 1988, 31, 475.
65. Grignaschi, G.; Samanin, R. Psychopharmacology, 1993, 110, 203.
66. Lightoweler, S.; Wood, M.; Brwon, T.; Glen, A.; Blackburn, T.; Tulloch, I.; Kennett, G. Eur. J. Pharmacol., 1996 296, 137.
67. Ayuso-Gutierrez, J.L. Palazon, M. Ayuso-Mateos, J.L. Int. J. Eating Disord., 1994, 15, 245.
68. Barnes, N.M.; Sharp, T. Neuropharmacology, 1999, 38, 1083.
69. Fichter, M.M.; Krüger, R.; Rief, W.; Holland, R.; Döhne, J. J. Clin. Psychopharmacol., 1996, 16, 9.
70. Wellman, P.J. Nutrition, 2000, 16, 837.
71. Wellman, P.J. Current Drug Targets, 2005, 6, 191.
72. Buckett, W.R.; Thomas, P.C.; Luscombe, G.P. Biol. Psychiatry, 1988, 12, 575.
73. McNeely, W.; Goa, K.L. Drugs, 1998, 56, 1093
74. Kelly, F.; Jones, S.P.; Lee, J.K. Int. J. Obesity, 1995, 19(Suppl.2), P397.
75. Jackson, H.C.; Bearham, M.C.; Hutchins, L.J.; Mazurkiewicz, S.E.; Needham, A.M.; Heal, D.J. Br. J. Pharmacol., 1997, 121, 1613.
76. Jackson, H.C.; Needham, A.M.; Hutchins, L.J.; Mazurkiewicz, S.E.; Heal, D.J. Br. J. Pharmacol., 1997, 121, 1758.
77. Halford, J.; Heal, D.J.; Blundell, J. Br. J. Pharmcol., 1995, 114, 387.
78. Connoley, I.P.; Liu, Y.L.; Frost, I.; Reckless, I.P.; Heal, D.J.; Stock, M.J. Br. J. Pharmacol., 1999, 126, 1487.
79. Liu, Y.L.; Connoley, I.P.; Harrison, J.; Heal, D.J.; Stock, M.J. Eur. J. Pharmacol., 2002, 452, 49.
80. Liu, Y.L.; Heal, D.J.; Stock, M.J. Int. J. Obes. Relat. Metab. Disord., 2002, 26, 1245.
81. Heal, D.J.; Cheetham, S.C.; Prow, M.R.; Martin, K.F.; Buckett, W.R. Br. J. Pharmacol., 1998, 125, 301.
82. Lean, M.E. Int. J. Obes. Relat. Metab. Disord., 2001, 25, S8.
83. Luscombe, G.P.; Hopcroft, R.H.; Thomas, P.C.; Buckett, W.R. Neuropharmacology, 1989, 28, 129.
84. Jackson, H.C.; Needham, A.M.; Hutchins, L.J.; Mazurkiewicz, S.E.; Heal, D.J. Br. J. Pharmacol., 1997, 121, 1758.
85. Heal, D.J.; Cheetham, S.C.; Prow, M.R.; Martin, K.F.; Buckett, W.R. Br. J. Pharmacol., 1998, 125, 301.
86. Boyer, P.; Briley, M. Drugs Today, 1998, 34, 709.
87. Mochizuki, D.; Tsujita, R.; Yamada, S.; Kawasaki, K.; Otsuka, Y.; Hashimoto, S.; Hattori, T.; Kitamura, Y.; Miki, N. Psychopharmacology, 2002, 162, 323.
88. Puech, A.; Montgomery, S.A.; Prost, J.F.; Solles, A.; Briley, M. Int. Clin. Psychopharmacol., 1997, 12, 99.
89. El-Giamal, N.; de, Zwaan, M.; Bailer, U.; Strnad, A.; Schussler, P.; Kasper, S. Neuropsychopharmacology, 2003, 13, 73.
90. Chaouloff, F. Brain Res. Brain Res. Rev., 1993, 18, 1.
91. Fone, K.C.; Topham, I.A. Pharmacol. Biochem. Behav., 2002, 71,815.
92. Laflamme, N.; Bovetto, S.; Richard, D.; Rivest, S. Br. J. Pharmacol., 1996, 117, 1021.
93. Nonogaki, K.; Iguchi, A. Life Sci., 1997, 60, 797.
94. Nonogaki, K.; Iguchi, A. Trends. Endocrinol. Metab., 1997, 8, 192.
95. Chaouloff, F.; Gunn, S.H.; Young, J.B. J. Pharmacol. Exp. Ther., 1992, 260, 1008.
96. Sugimoto, Y.; Yamada, J.; Yoshikawa, T.; Horisaka, K. Eur. J. Pharmacol., 1996, 307, 75.
97. Wadden, T.A.; Berkowitz, R.I.; Womble, L.G.; Sarwer, D.B.; Phelan, S.; Cato, R.K.; Hesson, L.A.; Osei, S.Y.; Kaplan, R.; Stunkard, A.J. N. Engl. J. Med., 2005, 353, 2111.
98. Bach, D.S.; Rissanen, A.M.; Mendel, C.M.; Shepherd, G.; Weinstein, S.P.; Kelly, F.; Seaton, T.B.; Patel, B.; Pekkarinen, T.A.; Armstrong, W.F. Obes. Res., 1999, 7, 363.
99. Zannard, F.; Gille, B.; Grentzinger, A, Bruntz, J.F.; Hammadi, M.; Boivin, J.M.; Hanotin, C.; Igau, B.; Drouin, P. Am. Heart J., 2002, 144, 508
100. Nisoli, E.; Carruba, M.O. Drug Safety, 2003, 26, 1027.
101. Padwal, R.; Majumdar, S.R. Lancet, 2007, 369, 71.